Relació d'ajuts convocats pels diferents organismes públics o privats, nacionals o internacionals.
Organitza: The Alzheimer’s Drug Discovery Foundation (ADDF) funds drug discovery and development research programs in the field of Alzheimer’s disease (AD), related dementias and cognitive aging.
Termini IISPV: Cal comunicar abans del 28 de desembre de 2012 que es vol participar a la convocatòria, enviant un e-mail a convocatories@iispv.cat . Termini: 14 de gener de 2013
Organitza: The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application. Novo Nordisk is a global healthcare company with 88 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk has approximately 32,700 employees in 75 countries, and markets its products in 190 countries.
Termini IISPV: Cal comunicar abans del 15 de desembre de 2012 que es vol participar a la convocatòria, enviant un e-mail a convocatories@iispv.cat . Termini IISPV 14 01 2013
Work
C/ Dr. Mallafrè Guasch, 4
Edifici modular Hospital Universitari de Tarragona Joan XXIII
43007 Tarragona
Tel./Fax Work977 24 97 72 http://www.iispv.cathttp://www.iispv.cat
Work
C/ Sant Llorenç, 21
Planta baixa de l'edifici 4 de la Facultat de Medicina i Ciències de la Salut
43201 Reus (Tarragona)
Tel./Fax Work977 75 93 96 / 977 75 93 95
Fax977 75 93 93
http://www.iispv.cathttp://www.iispv.cat